Muscle wasting in myotonic dystrophies: a model of premature aging by Alba Judith Mateos-Aierdi et al.
REVIEW
published: 09 July 2015
doi: 10.3389/fnagi.2015.00125
Muscle wasting in myotonic
dystrophies: a model of premature
aging
Alba Judith Mateos-Aierdi 1,2, Maria Goicoechea 1,2, Ana Aiastui 2,3,
Roberto Fernández-Torrón 1,2,4, Mikel Garcia-Puga 5, Ander Matheu 5 and
Adolfo López de Munain 1,2,4,6*
1 Neuroscience Area, Biodonostia Health Research Institute, San Sebastián, Spain, 2 CIBERNED, Instituto Carlos III,
Ministerio de Economía y Competitividad, Madrid, Spain, 3 Cell Culture Platform, Biodonostia Health Research Institute, San
Sebastián, Spain, 4 Department of Neurology, Hospital Universitario Donostia, San Sebastián, Spain, 5 Oncology Area,
Biodonostia Health Research Institute, San Sebastián, Spain, 6 Department of Neuroscience, Universidad del País Vasco
UPV-EHU, San Sebastián, Spain
Edited by:
Jaime J. Carvajal,






Fondazione Santa Lucia, Italy
*Correspondence:
Adolfo López de Munain,
Neuroscience Area, Biodonostia
Health Research Institute,
Paseo Dr. Begiristain s/n,
San Sebastián 20014, Spain
adolfo.lopezdemunainarregui@
osakidetza.net
Received: 27 March 2015
Accepted: 22 June 2015
Published: 09 July 2015
Citation:
Mateos-Aierdi AJ, Goicoechea M,
Aiastui A, Fernández-Torrón R,
Garcia-Puga M, Matheu A and López
de Munain A (2015) Muscle wasting
in myotonic dystrophies: a model of
premature aging.
Front. Aging Neurosci. 7:125.
doi: 10.3389/fnagi.2015.00125
Myotonic dystrophy type 1 (DM1 or Steinert’s disease) and type 2 (DM2) are
multisystem disorders of genetic origin. Progressive muscular weakness, atrophy
and myotonia are the most prominent neuromuscular features of these diseases,
while other clinical manifestations such as cardiomyopathy, insulin resistance and
cataracts are also common. From a clinical perspective, most DM symptoms are
interpreted as a result of an accelerated aging (cataracts, muscular weakness
and atrophy, cognitive decline, metabolic dysfunction, etc.), including an increased
risk of developing tumors. From this point of view, DM1 could be described as
a progeroid syndrome since a notable age-dependent dysfunction of all systems
occurs. The underlying molecular disorder in DM1 consists of the existence of
a pathological (CTG) triplet expansion in the 3’ untranslated region (UTR) of the
Dystrophia Myotonica Protein Kinase (DMPK) gene, whereas (CCTG)n repeats in
the first intron of the Cellular Nucleic acid Binding Protein/Zinc Finger Protein
9 (CNBP/ZNF9) gene cause DM2. The expansions are transcribed into (CUG)n
and (CCUG)n-containing RNA, respectively, which form secondary structures and
sequester RNA-binding proteins, such as the splicing factor muscleblind-like protein
(MBNL), forming nuclear aggregates known as foci. Other splicing factors, such
as CUGBP, are also disrupted, leading to a spliceopathy of a large number of
downstream genes linked to the clinical features of these diseases. Skeletal muscle
regeneration relies on muscle progenitor cells, known as satellite cells, which are
activated after muscle damage, and which proliferate and differentiate to muscle
cells, thus regenerating the damaged tissue. Satellite cell dysfunction seems to be
a common feature of both age-dependent muscle degeneration (sarcopenia) and
muscle wasting in DM and other muscle degenerative diseases. This review aims to
describe the cellular, molecular and macrostructural processes involved in the muscular
degeneration seen in DM patients, highlighting the similarities found with muscle
aging.
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Introduction
Myotonic dystrophy type 1 (DM1), also known as Steinert’s
disease (OMIM: 160900), is a dominantly inherited multisystem
disease. DM1 is the most common form of adult-onset muscular
dystrophy; it affects one out of 8000 people worldwide, with an
even greater prevalence in some specific areas such as Quebec
(Canada) and the Basque Country (Spain) (López de Munain
et al., 1993; Mathieu and Prévost, 2012). The DM1 phenotype
shows an extremely wide variability among affected patients, with
some being asymptomatic while others have severe congenital
forms. Patients are classified into four categories regarding the
age of onset of symptoms: late-onset, adult-onset, childhood-
onset and congenital forms (Harper, 2001; Arsenault et al.,
2006).
The disease is caused by an unstable expansion of a
trinucleotide (CTG) repeat motif located in the 3′ untranslated
region (UTR) of the Dystrophia Myotonica Protein Kinase
(DMPK) gene (Brook et al., 1992; Figure 1). Unaffected
individuals carry less than 50 triplet repeats, whereas expansions
ranging between 50 and 4000 CTG repeats have been found in
affected individuals. Importantly, the length of CTG expansion
is associated with the age of onset of the disease and its severity
(Martorell et al., 1998).
DM1 patients experience a progressive dysfunction of
multiple organs and tissues, including skeletal, cardiac and
smooth muscles, the endocrine system, eyes, gonads, the central
nervous system (CNS), and an increased risk of developing
neoplasias (López de Munain et al., 1993; Harper et al., 2002;
Gadalla et al., 2013). Thus, DM1 somewhat resembles a progeroid
syndrome, defined as an accelerated aging and dysfunction of
several systems.
A second form of myotonic dystrophy exists, DM type 2
(OMIM: 602668), initially named proximal myotonic myopathy
due to the greater weakness of proximal as compared to distal
muscles (Ricker et al., 1994). DM2 patients also develop a
multisystem dysfunction but they generally experience a milder
phenotype as compared to DM1 (Table 1). Consistent with
this, congenital and childhood-onset forms of DM2 are absent,
and the disease phenotype ranges from early adult-onset severe
forms to very late-onset mild forms (Day et al., 2003). The
prevalence of this disorder has yet to be clearly defined but
it is estimated to be similar to DM1 in Northern European
Countries (Udd and Krahe, 2012). However, very late-onset
FIGURE 1 | Representation of the DM-causing genes, the location of
the tandem repeats and their neighboring genes.
TABLE 1 | Summary of main clinical features that differ between both DM
forms.
Features DM1 DM2
Age of onset At any age Adulthood
Congenital forms Yes No
Gene expansion DMPK, (CTG)n CNBP, (CCTG)n
Predominantly affected muscles Distal Proximal
Predominantly affected fibers Type 1 Type 2
forms of this disease might often go undiagnosed due to its
mild phenotype, which can be concealed by other age-related
dysfunctions. Unlike what occurs in DM1, aging-like symptoms
in DM2 might not be so evident. Regarding the muscle-specific
phenotype, it is unknown why distal muscles are predominantly
affected in DM1 patients whereas DM2 patients show a more
proximal affectation.
As is the case with the genetic origin of DM1, DM2 is
caused by a tetranucleotide (CCTG) expansion in intron 1 of
the Nucleic Acid-binding Protein (CNBP or ZNF9) gene (Liquori
et al., 2001; Figure 1). Healthy individuals carry less than 30
tetranucleotide repeats, whereas repetition lengths between 55
and 11000 have been found in affected patients (Liquori et al.,
2001).
Skeletal muscle, one of the most severely affected tissues
in these diseases, may age prematurely in DM patients,
mimicking sarcopenia, known as the age-related loss of muscle
mass and function (Evans and Campbell, 1993; Fielding
et al., 2011). This syndrome can refer to loss of muscle
mass alone or in conjunction with fatty substitution (Fielding
et al., 2011). Although the causes of sarcopenia have not
as yet been accurately determined, several age-related factors,
such as muscle disuse, nutritional deficiencies, hormonal
changes and insulin resistance could notably contribute to its
onset.
Multisystem Dysfunction in DM
The previously described genomic tandem repeats lead to the
progressive degeneration of several tissues and organs, which is
more prominent in DM1 and milder in DM2 patients (Figure 2).
DM patients may suffer a broad variety of symptoms
affecting the three muscle types: cardiac, skeletal and smooth
muscles. Cardiac failure is common in DM1 patients, often
manifested as arrhythmias and conduction defects (Antonini
et al., 2000; Mammarella et al., 2000; Pelargonio et al., 2002;
Groh et al., 2008; Cudia et al., 2009; Petri et al., 2012). Although
congestive heart failure is a rare complication, subclinical
systolic dysfunction as shown by echocardiographic or magnetic
resonance imaging is frequent (De Ambroggi et al., 1995;
Tokgozoglu et al., 1995; Bhakta et al., 2004; Hermans et al.,
2011; Petri et al., 2012). The frequency of heart failure correlates
with age, male gender, length of the tandem repeat sequence
and the degree of neuromuscular disability (Tokgozoglu et al.,
1995; Antonini et al., 2000; Groh et al., 2008; Cudia et al.,
2009; Kaminsky and Pruna, 2012). Symptoms involving the
smooth muscle, such as dysphagia, constipation, intestinal
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FIGURE 2 | Summary of main symptoms affecting DM patients, which constitute the multisystem affectation found on them.
pseudo-obstruction and diarrhea, are also relatively frequent
in DM1 patients (Bujanda et al., 1997; Bellini et al., 2006;
Ercolin et al., 2013). As for skeletal muscle involvement, both
DM forms share common muscle histopathologic features,
with a markedly increased variation of fiber diameter and
prominent central nucleation, which is a feature of constantly
regenerating muscles with immature fibers. Other signs, such
as the presence of basophilic regenerating fibers, branched
fibers, and adipose and fibrotic tissue can also be found to
varying degrees, depending on the extent of muscle degeneration
and the severity of the disease. Although DM1 affects mainly
distal muscles and DM2 affects proximal muscles, only a
few DM type-specific features have been described. Among
these, ring fibers (peripheral myofibers that surround other
fibers) and sarcoplasmic masses are more frequently seen in
DM1 muscles. Nuclear clumps (condensed chromatin structures
in the myonuclei, indicating cell death) are found in DM2
patients even when muscular weakness is not clinically evident,
whereas they arise later in DM1 patients, mainly in end-
stage muscles (Vihola et al., 2010). Moreover, it must be
noted that DM1 muscles show a prominent loss of type 1
fibers, whereas type 2 fibers are predominantly affected in
DM2 patients (Vihola et al., 2003; Schoser et al., 2004; Bassez
et al., 2008; Pisani et al., 2008). Interestingly, the histology of
DM muscles resembles that of aged muscles, with fiber size
variability, centrally located nuclei with chromatin clumps and
fiber atrophy. Muscle regeneration also seems to be decreased in
both conditions, probably due to satellite cell dysfunction, which
may fail to activate and/or differentiate to muscle uponmyogenic
stimuli (Huichalaf et al., 2010; Malatesta, 2012; Malatesta et al.,
2014).
As part of the multisystem involvement, many DM1 patients
show insulin resistance due to the aberrant splicing of the
insulin receptor (IR) mRNA, which is highly expressed in skeletal
muscle. Consequently, patients show a reduced responsiveness to
insulin as compared to healthy individuals (Morrone et al., 1997;
Savkur et al., 2001).
The CNS is also negatively affected in DM1 patients.
The large majority of congenital and childhood-onset DM1
patients suffer mental retardation, whereas patients with the
adult-onset forms may show varying degrees of cognitive
dysfunction, where a positive correlation is observed between
triplet expansion length and patients’ age. Cognitive dysfunction
is characterized by a dysexecutive syndrome with predominant
frontoparietal involvement (Sistiaga et al., 2010). Moreover,
DM1 patients go through behavioral-personality changes (e.g.,
reduced initiative, inactivity, apathic temperament and paranoid
personality traits) and excessive daytime sleepiness. There is
tentative data supporting an age-dependent decline of cognitive
functioning in DM1 patients (Modoni et al., 2008), possibly
associated with the degeneration of the diffuse (predominantly
temporo-insular) subcortical white matter, and a reduction
of the cerebral blood flow in frontal areas (Romeo et al.,
2010).
DM1 patients also present hepatic involvement. Indeed, 66%
of patients show abnormal hepatic enzyme levels and non-
alcoholic steatosis (Achiron et al., 1998). Ocular complications,
including ptosis, weakness of the ocular muscle and cataracts are
also common in DM1 patients, and other less frequent features,
such as retinal changes or macular degeneration, may also be
present in these patients (Kimizuka et al., 1993; Krishnan and
Lochhead, 2010).
Finally, DM patients may also suffer fertility dysfunction.
Approximately two thirds of affected males have reduced sperm
quality as a result of testicular atrophy (Pan et al., 2002). Affected
female fertility is less well documented (Verpoest et al., 2008),
but the length of triplet expansion does not seem to be correlated
with this aspect of the disease. Importantly, the age of the
pregnant patient and parity significantly affect the live birth
delivery rate (Verpoest et al., 2010).
In order to decipher why some specific tissues are more
severely affected than others in these diseases, it must be
highlighted that some tissues and cell types possess a higher
tendency to extend these tandem repeat sequences. This leads
to the existence of cells with different repeat lengths within an
organism, known as somatic mosaicism. The longest tandem
repeats have been found in severely affected tissues; indeed,
skeletal muscle cells possess considerably longer repeat sequences
as compared to other cell types (Anvret et al., 1993; Thornton
et al., 1994). Importantly, cells with longer tandem repeats
tend to accumulate more repetitions than cells with shorter
repeat sequences (Monckton et al., 1995), thus aggravating
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the degenerative state of predominantly affected tissues in
these patients, such as the CNS and cardiac and skeletal
tissues.
In addition to somatic cells, germline cells are also prone to
genomic instability and thus accumulate tandem repeats in DM.
This leads to anticipation, which refers to the increase in disease
severity and decrease in the age of onset in each generation of
affected families (López de Munain et al., 1994).
Repeat Expansion Mechanisms in DM
As previously mentioned, somatic mosaicism is an important
feature of myotonic dystrophies; tandem repeats increase with
aging in an unsynchronized fashion, leading to cells with
different repeat lengths in their genomes. Furthermore, somatic
instability is prevalent in highly affected tissues, such as skeletal
muscle (Morales et al., 2012).
Slippage of DNA polymerase during DNA replication was
at first considered the main mechanism through which repeat
sequences are expanded in myotonic dystrophies. Therefore,
highly proliferative cells would have a higher tendency to expand
DNA repeat sequences, which contradicts the fact that the longest
tandem repeats are found in severely affected tissues that happen
to be post-mytotic. In this regard, DNA repair mechanisms,
which are also active in non-cycling cells, have been found to
notably contribute to this phenomenon (van den Broek et al.,
2002; Savouret et al., 2003; Kovtun et al., 2004; Seriola et al., 2011;
Gomes-Pereira et al., 2014), which could explain the elongation
of tandem repeats in non-proliferating cells in culture (Gomes-
Pereira et al., 2014).
DNA tandem repeats in DM acquire secondary
conformations, usually forming hairpin structures. DNA repair
proteins recognize these structures and may abnormally repair
them, varying the repeat length (McMurray, 2008). Knock-out
animal models for components of the DNA repair machineries,
as well as silencing these genes in patient-derived cultures, reduce
or even abrogate the elongation of repeat expansion sequences.
For example, it has been established that Msh2, a component of
the mismatch repair (MMR) machinery, is required for triplet
expansion in DM1-derived pluripotent stem cells (iPS) cells, as
its silencing blocks the expansion of the triplet repeat sequence
(Du et al., 2013). Knock-down and overexpression experiments
of proteins involved in Base Excision Repair (BER) systems in
yeast also indicate that these proteins might play a role in the
expansion of repeat sequences (Refsland and Livingston, 2005;
Subramanian et al., 2005). However, this fact has not been fully
demonstrated in mice due to the lethality of knock-out mouse
models for these proteins (Xanthoudakis et al., 1996; Tebbs et al.,
1999).
The fact that skeletal muscle is composed of postmitotic cells
suggests that these DNA repair systems may contribute in a
major way to the expansion of repeat sequences in these tissues.
Interestingly, a study performed by Vahidi Ferdousi et al. (2014)
shows that double-strand breaks produced by irradiation are
more rapidly repaired in muscle satellite cells than their progeny,
thus indicating that satellite cells possess a more efficient DNA
repair system, which usually acts through non-homologous
end joining. Therefore, it could be hypothesized that triplet
expansions are predominantly elongated in satellite cells due
to the high activity of the DNA-repair system in these cells.
This is consistent with the muscle degeneration seen in DM
patients, as dysfunction of satellite cells would disrupt muscle
regeneration.
Recent studies have shown that, in addition to DNA repair
molecules, the 26S proteasome also participates in the expansion
of tandem repeat sequences (Debacker et al., 2012; Concannon
and Lahue, 2013). Importantly, the proteolytic activity of 26S,
rather than the stress-induced activation of the ubiquitin-
proteasome system (UPS), is implicated in this elongation
process. Indeed, DNA repair mechanisms could interact with
the proteasome to induce repeat expansions through Rad23, a
protein involved in both nucleotide excision repair (NER) system
and the carriage of ubiquitinated proteins to the proteasome
(Concannon and Lahue, 2014).
Pathogenic Mechanisms in DM
It is remarkable that severely affected tissues in DM possess
very low mitotic rates. Interestingly, in vitro experiments have
shown that nuclear foci tend to predominantly accumulate in
non-cycling cells. Cycling DM2 fibroblasts accumulate nuclear
foci during interphase but these are cleared out during mitosis,
leading to mitosis-dependent cycles of foci formation and
disassembly. On the contrary, mitotically arrested fibroblasts
accumulate more foci, which keep enlarging progressively
(Giagnacovo et al., 2012). In this regard, muscle biopsies of
DM2 patients have confirmed that the size of myonuclear
foci increases in an age-dependent manner (Giagnacovo et al.,
2012). Therefore, this could help clarify why tissues and cell
types with low mitotic rates are preferentially affected in these
diseases.
Several mouse models have been created to study the
pathogenic mechanisms of DMs. These models can be
categorized into 4 subgroups regarding the genetic modifications
that have been introduced in order to mimic different molecular
aspects of the diseases: (i) introduction of unstable CTG repeat
sequences; (ii) overexpression of toxic CTG/CCTG repeats;
(iii) inactivation of the genes located in the DM1 locus; and
(iv) mice models of MBNL inactivation or CUGBP1/CELF
overexpression (Gomes-Pereira et al., 2011).
Based on these studies, three pathogenic mechanisms that
link the nucleotide expansion with the clinical manifestation of
myotonic dystrophies have been proposed: (a) DMPK and CNBP
haploinsufficiency; (b) Cis alteration of neighboring genes; and
(c) RNA-induced toxicity (Figure 3).
Haploinsufficiency
Haploinsufficiency refers to the deleterious effect of having only
one wild type copy of a gene in the phenotype of the organism.
DMpatients carry only one wild type copy of theMDPK orCNBP
gene, as the other copy harbors the tandem repeats that form
nuclear foci, therefore reducing the amount of DMPK or CNBP
protein synthesized.
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FIGURE 3 | Representation of potential pathogenic mechanisms that explain the effect of DNA expansions in DM1-affected cells and the phenotype
seen in patients.
DMPKs is a serine-threonine kinase, whose function in
skeletal muscle is not fully understood. It has been shown
to localize in the nuclear membrane, where it interacts with
lamin-A/C and its deficiency leads to nuclear envelope
instability (Harmon et al., 2011). However, it has also been
found in the cytoplasm and the cellular membrane during cell
division and cardiomyocyte differentiation (Harmon et al.,
2008). Depletion of DMPK reduces myogenin expression
and prevents proper myoblast differentiation (Harmon
et al., 2008). Other studies have also shown that DMPK
can phosphorylate the myosin-binding subunit of myosin
phosphatase (MYPT1), which inhibits myosin phosphatase
(PP1c) activity (Murányi et al., 2001). DMPK also phosphorylates
the SERCA2a inhibitor Phospholamban, thus regulating
calcium uptake in cardiomyocytes (Kaliman et al., 2005), and
Phospholemman, a regulator of Na, K-ATPase (Mounsey et al.,
2000).
As for DM2, CNBP is a nucleic-acid binding protein that
mainly binds single stranded DNA and RNA, and modulates
the transcription of genes involved in Wnt signaling pathway
(Margarit et al., 2014).
The proposed pathogenic mechanism hypothesizes that
reduced DMPK and CNBP/Znf9 levels in DM1 and DM2,
respectively, cause the onset of the diseases. Consistent with this,
decreased amounts of DMPK transcripts and protein have been
detected in DM1 patients, and this decrease inversely correlated
with the CTG repeat length (Fu et al., 1993).
In this regard, DMPK knock-out mice fail to reproduce
the multisystem phenotype of DM1 patients, and only develop
late-onset myopathy (Jansen et al., 1996; Reddy et al., 1996;
Berul et al., 1999), suggesting that haploinsufficiency of
DMPK is not the primary mechanism that initiates this
disease.
On the contrary, Znf9+/− mice (lacking one CNBP allele)
develop a multisystem phenotype resembling DM, including
muscle wasting, heart failure and cataracts (Chen et al., 2007),
which suggests that CNBP insufficiency may have a role in the
pathologic mechanisms of DM2 (Raheem et al., 2010). However,
other studies have yielded contradictory results, indicating that
aberrant CCTG expansions do not alter CNBP protein levels, and
thus, CNBP deficiency would not contribute to the onset of the
disease (Margolis et al., 2006).
Cis-Alteration of Neighboring Genes
Tandem repeats produce changes in chromatin structure. Indeed,
nucleosomes tend to localize in these repeat sequences, inducing
chromatin condensation (Wang et al., 1994; Volle and Delaney,
2012), which could have a notable impact on the transcriptional
activity of DMPK and ZNF9 flanking genes (Klesert et al., 1997;
Thornton et al., 1997; Westerlaken et al., 2003). Similar to the
haploinsufficiency of the repeat-containing genes in myotonic
dystrophies, the altered expression of genes located in the
neighborhood of the disease-causing genes could also contribute
to the molecular mechanisms leading to these diseases.
In line with this, mRNA level of SIX5 (also known
as DMAHP), a transcription factor coding gene located
downstream of DMPK, is reduced in DM1 patients (Klesert et al.,
1997; Thornton et al., 1997; Westerlaken et al., 2003). Expression
of DMWD, an upstream DMPK flanking gene, also seems to
be somewhat reduced in the cytoplasm of DM cells, although
nuclear levels remain unchanged (Alwazzan et al., 1999; Frisch
et al., 2001).
In order to ascertain the contribution of reduced levels of
SIX5 to the development of DM1, a knock-out mouse model
of SIX5 was created. Besides showing an increased susceptibility
to developing cataracts (Klesert et al., 2000; Sarkar et al., 2000),
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reduced fertility in males (Sarkar et al., 2004) and altered
cardiac function (Wakimoto et al., 2002), these mice do not
show multisystem involvement and thus fail to recapitulate the
dystrophic phenotype of DM1 patients.
RNA-Induced Toxicity
The third pathogenic mechanism proposes that repeat
expansions, once translated into RNA, exert a gain-of function
toxic effect in the cells. The expanded CUG-containing
transcripts form secondary structures of a hairpin shape
(Michalowski et al., 1999) and sequester specific RNA-binding
proteins that participate in pre-mRNA transcription and
maturation, such as MBNL (Muscleblind-like) (Miller et al.,
2000), thus leading to splicing defects in both DM1 and
DM2 patients (Du et al., 2010; Malatesta and Meola, 2010).
Double-strand RNA structures also abnormally activate the
RNA-dependent protein kinase R (PKR), which in turn
hyperphosphorylates CUG-BP/CELF1 protein and alters its
function (Tian et al., 2000). This protein is involved in the
splicing of several genes directly implicated in the multisystem
phenotype of DM patients, such as cardiac Troponin (cTNT),
IR and chloride channel 1 (CLCN1; Osborne et al., 2009).
Overactivation of PKR also inactivates its substrate eIF2α,
inhibiting the translation of specific mRNAs, such as the DNA
repair factor MRG15 (Huichalaf et al., 2010).
In order to assess the contribution of foci formation to
the multisystem involvement seen in DM patients, several
mouse models have been created carrying variable repeat length
sequences and tissue specificity. In all these models the toxicity
of foci has been tested, and such models have helped to
elucidate how these aggregates play a key role in the onset of
the disease. For example, HSA mice, which harbor 5 (short
repeat length, HSASR) or 250 (long repeat length, HSALR) CTG
repeats in the Human Skeletal Actin gene (HSA), thus inducing a
muscle-specific expression of tandem repeat-containing RNAs,
have clearly established the role of RNA-protein aggregates
in the development of the disease, as mice harboring long
repeats developed a DM-like phenotype of muscle degeneration
(Mankodi et al., 2000). RNA toxicity has been confirmed with
transgenic mice harboring long triplet repeats in the DMPK
gene. Such mice develop multisystem abnormalities mimicking
the human DM phenotype, with predominant involvement of
muscles and the CNS, although the resulting phenotype is
milder than in other mouse models of the disease (Seznec et al.,
2001).
Therefore, all three mechanisms may participate to some
extent in the onset of a range of symptoms in DM patients,
although RNA toxicity seems to contribute most notably to the
multisystem degeneration seen in DM patients.
Age-Related Genomic Events in DM
Cellular aging is accompanied by accumulating DNA damage
(Moskalev et al., 2013), which includes point mutations,
translocations, and double strand breaks, among others. These
mutations can seriously affect the functionality of several cell
types, such as the regenerative capacity of stem cells. Cells possess
several mechanisms to cope with these abnormalities, either
by activating DNA repair mechanisms or inducing cell death.
Unfortunately, DNA damage increases with aging partially due
to decreased efficiency of DNA repair systems (Gorbunova et al.,
2007).
As previously mentioned, these DNA repair mechanisms
participate in the expansion of tandem repeats, which cause
not only DM but also other degenerative diseases such as
Huntington’s Disease and Friedreich’s ataxia. Besides DNA
repair mechanisms, telomere maintenance could also be
implicated in muscle aging and DM.
Chromosomal ends, also known as telomeres, are composed
of highly repetitive sequences that play an important role in the
maintenance of chromosomal structure. Importantly, these DNA
ends cannot be replicated by common DNA polymerases and
thus, they continue to shorten in every cell division. Telomere
shortening has been observed in most cell types during the
aging of both human and mice tissues (Blasco, 2007) and has
become a cellular marker of aging. However, some cell types,
such as most adult stem cells, express telomerase, a specific
enzyme able to replicate telomeric sequences, counteracting their
shortening (Vaziri et al., 1994; Chiu et al., 1996; Morrison et al.,
1996; Espejel et al., 2004; Ferrón et al., 2004; Flores et al.,
2005).
Absence of telomere shortening in satellite cells of aged
mice, together with the insignificant reduction of telomerase
activity in aged muscle stem cells, indicates that satellite cells
possess mechanisms to maintain telomeres, and thus, the age-
related reduction of their regenerative potential is telomere
independent. On the contrary, myogenic differentiation of these
satellite cells abolishes their telomerase activity (O’Connor et al.,
2009).
In vitro studies with human congenital DM1 samples show
that despite DM1-affected satellite cells having a higher telomere
shortening rate, these cells enter senescence prior to reaching
critically short telomere lengths (Bigot et al., 2009; Thornell et al.,
2009). In these cases, p16-dependent signaling seems to induce
the senescence of satellite cells. Thus, telomere shortening, even
though it is altered in DM1 patients, does not seem to play a
role in the pathology of this disease. On the contrary, telomere
shortening could influence the regenerative capacity of DM2-
affected satellite cells, as will be discussed below Renna et al.
(2014).
Epigenetic Modifications in DMs and Aging
Epigenetic modifications encompass post-translational
modifications of DNA and histones that lead to chromatin
remodeling processes. Different trends of these modifications
have been associated with aging, such as increased histone
H4K16 acetylation, H4K20 trimethylation and H3K4
trimethylation, and decreased H3K9 methylation or H3K27
trimethylation (Fraga and Esteller, 2007; Han and Brunet, 2012;
López-Otín et al., 2013). Importantly, the family of histone
deacetylases known as sirtuins have been shown to possess
outstanding antiaging potential (Kaeberlein, 2008; Houtkooper
et al., 2012; Imai and Guarente, 2014).
Frontiers in Aging Neuroscience | www.frontiersin.org 6 July 2015 | Volume 7 | Article 125
Mateos-Aierdi et al. Muscle wasting in myotonic dystrophies
Epigenetic modifications also seem to correlate with the age-
dependent loss of the regenerative potential of stem cells (Liu and
Rando, 2011). This also applies to muscle satellite cells, in which
H3K27 trimethylation seems to increase overall in their genome,
along with reduced histone biosynthesis (Liu et al., 2013).
Although epigenetic modifications in DM-affected satellite
cells have not yet been studied specifically, triplet expansions
seem to induce different DNA methylation patterns. In this
regard, the DMPK locus shows a variably methylated sequence
upstream of the triplet expansion, whereas this sequence is
unmethylated in healthy controls (Ghorbani et al., 2013).
Interestingly, the expanded sequence and the downstream
sequence are not methylated (López Castel et al., 2011).
Methylation is more frequently found in tissues of congenital
and young-onset patients, although it is not limited to cells with
the largest expansions or to specific tissues (López Castel et al.,
2011). In an attempt to elucidate the consequences of these
methylations, disruption of CTCF binding to its DNA binding
sites, which flank the DM1 locus, has been postulated to explain
the reduced transcription of DMPK and Six5 genes (Filippova
et al., 2001; He and Todd, 2011). However, CTCF binding to
DNA seems to be unaffected in a mouse model of DM1, despite
the methylation and heterochromatinization found in the DM1
locus (Brouwer et al., 2013). These authors alternatively propose
proliferating cell nuclear antigen (PCNA), which also binds DNA
repeat sequences, as a player in the triplet-expansionmechanism.
The epigenetic modifications resulting from triplet
expansions require more precise study in order to determine
their contribution to the development of the disorder. The study
of these modifications in muscle satellite cells would contribute
to unravel the role of epigenetic modifications in the regenerative
capacity of DM-affected satellite cells.
Is Muscle Wasting in Myotonic Dystrophy a
Matter of Premature Aging?
Satellite Cells and Muscle Regeneration in DM
and Aging
Satellite cells play a key role in the maintenance of muscle
structure and function both in homeostasis and after acute
damage. The age-related dysfunction of satellite cells has been
postulated to be a key cause of sarcopenia, apart from also being
implicated in other muscle wasting conditions such as muscular
dystrophies (Day et al., 2010).
Satellite cells maintain skeletal muscle structure and
functionality by differentiating into myogenic cells that
regenerate muscle tissue (Lepper et al., 2011; Murphy et al.,
2011; Sambasivan et al., 2011). In adulthood, these cells are
quiescent and locate in the periphery of muscle fibers, between
the basal membrane and the sarcolemma (Mauro, 1961). When
muscle regeneration is required, these cells activate the cell cycle
and proliferate. Most of these activated satellite cells enter the
myogenic program and differentiate into myoblasts that fuse to
each other or to preexisting myotubes, regenerating the damaged
tissue. However, a small subpopulation of these cells repopulates
the satellite cell niche (Chargé and Rudnicki, 2004; Yin et al.,
2013).
Age-dependent regenerative dysfunction of skeletal muscle
mainly depends on the decreased amount and functionality of
satellite cells (Shefer et al., 2006; Brack and Rando, 2007; Collins
et al., 2007). However, it has been widely debated if this reduced
regenerative potential is due to extrinsic factors, such as age-
dependent alterations of the satellite cell niche and circulating
factors (Brack and Rando, 2007; Gopinath and Rando, 2008;
Urciuolo et al., 2013), or due to intrinsic defects of these stem
cells (Bernet et al., 2014; Sousa-Victor et al., 2014).
With regard to extrinsic factors, satellite cells are responsive to
a wide variety of circulating biomolecules, whose concentration
is constantly being modified in an age-dependent manner.
Experiments involving surgical sharing of the circulating system
(also known as heterochronic parabiosis) between aged and
young mice have revealed that aged serum harbors factors
that reduce the regenerative capacity of young satellite cells,
whereas young serum is able to partially revert the myogenic-to-
fibrogenic transition of aged muscle stem cells, thus reducing the
muscle fibrosis seen in old muscles (Conboy et al., 2005; Brack
and Rando, 2007). In vitro experiments performed with human
satellite cells have confirmed this fact. These findings show that
age-dependent systemic factors act on the regenerative potential
of satellite cells (Carlson and Conboy, 2007; Carlson et al., 2009).
The satellite cell niche, composed of cells and extracellular
matrix located in the close vicinity of satellite cells, also
affects satellite cell functionality, probably through secreted
factors as well as cell-to-cell interactions (Murphy et al.,
2011; Naito et al., 2012). Moreover, aging alters the pattern
of secreted molecules and cellular interactions, thus affecting
satellite cell biology. For example, age-dependent increases in
basic fibroblast growth factor (bFGF) activate satellite cells in
homeostasis, inducing their differentiation, and consequently,
the satellite cell pool is depleted (Chakkalakal et al., 2012).
On the other hand, matrix molecules, such as extracellular
fibronectin, participate in the activation of Wnt signaling in
satellite cells, promoting their symmetric division (Bentzinger
et al., 2013).
Apart from environmental factors, satellite cell-intrinsic
factors also play a central role in the maintenance of the
regenerative capacity of these cells. Recently, Sousa-Victor et al.
(2014) have demonstrated that the pronounced decline in the
regenerative potential of satellite cells in very old (geriatric)
mice is caused by the induction of p16Ink4a, which drives cells
from quiescence to irreversible senescence. p38 signaling also
occupies a central role in the functionality of satellite cells. In
this regard, activation of p38 signaling in dividing aged satellite
cells induces the differentiation of both daughter cells, whereas
in young animals, asymmetric localization of p38 enables satellite
cells to divide asymmetrically, thus favoring the maintenance of
the quiescent satellite cell pool (Bernet et al., 2014; Cosgrove et al.,
2014).
Therefore, both satellite cell-extrinsic and -intrinsic factors
affect the regenerative potential of muscle stem cells during
aging and these factors may also play a role in DM-affected
satellite cells. Indeed, it has been shown that cell-intrinsic events,
such as nuclear foci accumulation, affect DM cell functionality
(Malatesta, 2012), whereas the multisystem dysfunction seen in
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these diseases may probably alter circulating factors, impairing
the regenerative potential of these cells.
Several studies have aimed to study the involvement of
satellite cells in DM. In this regard, histopathologic analysis
of severely affected distal muscles vs. slightly affected proximal
muscles of DM1 patients has shown a two-fold increase in
the number of satellite cells in severely affected muscles.
Interestingly, telomere length is not altered and the number of
regenerative fibers is low in both distal and proximal muscles
(Thornell et al., 2009). In this regard, in vitro proliferative
capacity of DM1 satellite cells is considerably reduced, and
their entry into senescence is telomere-independent (Thornell
et al., 2009). Indeed, this has been corroborated with in
vitro cultured satellite cells from congenital DM fetuses and
newborns. These satellite cells show a considerably lower
proliferative rate than age-matched controls, besides having
activated senescence-associated beta galactosidase, high levels
of cyclin D1 and hypophosphorylated Rb. Interestingly, these
cells also enter senescence prior to reaching critically short
telomere lengths and express p16Ink4a, a Cdk4 inhibitor that
induces cell cycle arrest (Bigot et al., 2009). It remains to
be clarified which cellular events induce p16Ink4a expression,
although disturbed DNA functioning due to the formation
of unusual structures, as well as increased free radicals and
oxidative stress might be involved in the activation of this
gene.
Besides the involvement of the proliferative capacity of
DM satellite cells, the myogenic program is also abnormal
in these cells. Indeed, there is evidence of the defective
differentiation and maturation of DM1 myogenic progenitors
in vitro, resulting in smaller and thinner myotubes, with a
30% lower fusion index and the lack of expression of mature
myosin forms (Furling et al., 2001). This lack of fiber maturation
has also been confirmed in DM1 muscle biopsies, where
late myogenic differentiation markers are not fully expressed
(Vattemi et al., 2005). Moreover, DM1 myoblasts seem to
have impaired cell cycle withdrawal, probably due to the
inability to induce the expression of p21 (Timchenko et al.,
2001).
Satellite cells in DM2 show an intermediate phenotype
between DM1 and healthy satellite cells. Renna et al. (2014)
suggest that DM2 satellite cells also show premature entry into
senescence, although later than DM1 satellite cells. Importantly,
senescence seems to correlate with telomere shortening rather
than the induction of p16Ink4a (Renna et al., 2014). In contrast
to DM1 progenitors, DM2 progenitors did not show any
differentiation defects and CGUBP1 levels were also unchanged.
However, DM2 cells had abnormal IR splicing (Pelletier et al.,
2009). In this regard, the interaction of CUGBP1 with eIF2α
and Cyclin D3-CDK4/6 seems to be crucial to achieve a correct
myogenic differentiation. Reduction of these interactions in
DM1 cells could explain the impaired differentiation of these cells
(Salisbury et al., 2008).
This reduced differentiation and premature senescence
of satellite cells resembles physiological satellite cell aging.
Moreover, age-related cell-senescence features, such as
cytoplasmic vacuolization, accumulation of heterochromatin
and impaired pre-mRNA maturation (Malatesta and Meola,
2010) have also been found in DM cells (Malatesta et al.,
2011a,b).
As previously mentioned, secreted factors also have an impact
on muscle regeneration during aging, and could also play a role
in DM. In this regard, congenital DM1 muscle progenitor cells
with long triplet expansions seem to secrete prostaglandin, which
in turn hampers myogenic differentiation, probably by lowering
intracellular calcium levels (Beaulieu et al., 2012).
Loss of Proteostasis in Aging and DM
Proteostasis encompasses cellular mechanisms that preserve
the stability and functionality of its proteome in order to
prevent the accumulation of damaged proteins and ensure
continuous renewal of intracellular proteins. Many studies
have demonstrated that protein homeostasis collapses during
aging, leading to the accumulation of unfolded, aggregated
and misfolded proteins, a phenomenon that causes several
age-related diseases (Powers et al., 2009). Cells have various
mechanisms to tackle these protein failures. The three
principal proteostatic systems are the UPS, the autophagy-
lysosomal system and chaperones, the efficiency of all of which
decreases with aging (Calderwood et al., 2009; Tomaru et al.,
2012). Consequently, old cells carry more non-enzymatic
posttranslational protein modifications and accumulate more
cross-linked and aggregated proteins than young cells (Soski´c
et al., 2008).
The Ubiquitin-Proteasome System
The UPS actively participates in the regulation of protein
synthesis and degradation. The age-dependent decay of UPS
efficiency may be the result of the reduced expression
of proteasome subunits, their inadequate assembly, and/or
reduced ATP availability due to mitochondrial dysfunction
(Chondrogianni et al., 2014).
The activity of UPS is reduced in several aged mammals,
such as humans, mice, rats and sheep. However, contrary to
what could be expected, some aged tissues such as muscle, show
increased expression of UPS subunits (Ferrington et al., 2005),
which could be a compensatory effect for reduced constitutive
proteasomal activity (Husom et al., 2004). Maintenance of
proteostasis in stem cells may also play an important role in
organismal aging (Vilchez et al., 2014). Indeed, proteasome
activation is a conserved mechanism that regulates aging and
longevity (Chondrogianni et al., 2014).
The breakdown of proteostasis has been linked to several
disorders, including myotonic dystrophy. UPS is increased in
skeletal and cardiac muscle of transgenic DM mice with 550
CTG repeats, triggered by the up-regulation of Fbx032/Atrogin-
1 and/or Trim63/Murf1. These mice develop progressive muscle
weakness between 3 and 10 months of age (Vignaud et al., 2010).
Overactivation of UPS has also been confirmed in the DMSXL
mouse model, which exhibits more than 1.000 CTG repeats. UPS
activity was considerably increased at 4 months of age in these
mice, suggesting that this proteolytic pathway could play a role
in the physiopathological remodeling of muscle (Huguet et al.,
2012).
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Proteomic analyses have also confirmed that protein
degradation is altered in DM2 myotubes (Rusconi et al., 2010).
Indeed, an overall reduction in ubiquitinated proteins as well as
reduced proteasome subunits have been found in DM2myotubes
(Rusconi et al., 2010). DM2 myoblasts degrade faster a variety
of short-lived proteins, such as c-myc and p21, due to increased
UPS activity that results from RNA CCUG repeats that bind
the 20S core complex (Salisbury et al., 2009). Skeletal muscles
of DM2 patients also show a deregulated neural precursor cell
expressed developmentally down-regulated protein 4 (NEDD4)
ubiquitin ligase-PTEN pathway, which could contribute to the
increased risk of statin-adverse reactions in patients with DM2,
due to PTEN accumulation in highly atrophic muscle fibers
(Screen et al., 2014).
It is worthy of note that besides UPS overactivation inDM, the
26S proteasome itself is implicated in trinucleotide expansion,
thus favoring the expansion of these pathogenic repeat sequences
(Concannon and Lahue, 2014).
Autophagy
Autophagy mediates the degradation of cellular components in
order to recycle them or to obtain energy. Indeed, autophagy
is activated during starvation and induces the degradation
of cellular components, providing the cell with energy and
thus promoting cell survival during a period of low nutrient
availability. In contrast to autophagy, mTOR signaling is
activated by high nutrient availability, such as insulin and
amino acids, and activates cell division and protein synthesis.
Importantly, age-dependent decline of autophagy disrupts
cellular proteostasis.
In skeletal muscle, autophagy seems to participate in the
activation of quiescent satellite cells, probably providing the
additional energy required for this process (Tang et al., 2014).
Thus, age-related dysfunction of autophagy could undermine
satellite cell activation with aging.
In vitro myoblast cultures of DM1 patients show that
nearly half of the myoblasts undergo abnormal differentiation.
Strikingly, cells that fail to differentiate show autophagic features
after 6 days in culture, with increased cellular volume and a high
density of autophagic vacuoles as compared to control and DM1
differentiated cells (Beffy et al., 2010). Senescence was ruled out
as an activator of autophagy in this study, as the percentage
of cells expressing senescence-associated beta galactosidase was
similar in DM1 cells and controls.
Autophagy may also be abnormal in DM1-affected neurons.
In this regard, autophagy has been found to be activated and
mTOR signaling partially inhibited in DM1-hESC-derived
neurons as compared to wild type-hESC-derived neurons.
Phosphorylation of the mTOR downstream components
GSK3α/β and rpS6 were decreased in these cells. Importantly,
reduction of mTOR signaling was p53-independent, therefore
suggesting that inhibition of mTOR is not induced by cellular
stress (Denis et al., 2013). In line with this, GSK3β has been
found to be overactivated in muscles of the DM1 mouse model
HSALR prior to the onset of muscle wasting, and GSK3β blockers
improved skeletal muscle strength and reduced myotonia in
this mouse model, suggesting that these inhibitors could have a
beneficial effect on the treatment of DM1 by alleviating muscle
wasting (Jones et al., 2012).
It has been speculated that autophagy could be a mechanism
either to avoid apoptosis or to protect cells against metabolic
stress. However, transfection of C2C12 myoblasts with the
human DMPK-A isoform not only shows increased autophagy,
but also enhances apoptosis (Oude Ophuis et al., 2009).
Therefore, autophagy in DMmust be thoroughly studied in order
to determine the causes and the effects of its overactivation in
these patients.
Chaperones
Chaperones exert a key function in proteostasis by folding
peptides, refolding incorrectly folded proteins and unfolding
damaged proteins to facilitate their degradation. Heat Shock
Proteins (HSPs) constitute a subgroup of chaperones that
are specifically induced by different cell stressors, such as
protein damage. As expected, chaperones play a central role in
protecting cells from protein damage and cell death during aging
(Calderwood et al., 2009). Moreover, experiments performed
in S. cereviasiae have shown that overexpression of specific
HSPs, such as HSP104, increases protein disaggregation, reduces
protein accumulation and restores UPS in aged cells (Andersson
et al., 2013).
The muscle-specific HSPs HSPB3 and HSPB2, the latter
also known as Myotonic dystrophy Protein Kinase Binding
Protein (MKBP), seem to occupy a central role in muscle
regeneration. HSBP2 specifically binds and activates MDPK,
which contributes to muscle maintenance (Suzuki et al., 1998;
Prabhu et al., 2012). HSBP2 and HSBP3 are induced by
MyoD during myogenic differentiation, which strongly suggests
that they play central roles in muscle regeneration, probably
through the interaction of MKBP with DMPK (Sugiyama et al.,
2000). Other HSPs, such as HSP70, may also play muscle-
specific roles, as it is induced in type 1 fibers (Locke et al.,
1991).
Expression of HSPB2/MKBP is specifically up-regulated in
the skeletal muscle of DM1 patients, probably in order to partially
compensate for the reduced amount of DMPK (Sugiyama
et al., 2000). Therefore, an increase in chaperone activity
would potentially benefit the maintenance of skeletal muscle
functionality in both DM-affected and aged muscles.
Mitochondrial Dysfunction
The Mitochondrial Free Radical Theory of Aging (MFRTA),
which proposes that mitochondrial free radicals cause oxidative
damage that gives rise to cellular aging, has been postulated
as one of the main hypotheses to explain how cells age (Sanz
and Stefanatos, 2008). Mitochondria play an important role in
mediating and amplifying the oxidative stress that drives the
aging process (Bratic and Larsson, 2013).
The largest isoform of myotonic dystrophy protein kinases,
DMPK-A, supplies antioxidants and antiapoptotic signals
needed for correct muscle fiber function and differentiation (van
Herpen et al., 2005; Pantic et al., 2013). However, anchorage and
accumulation of DMPK-A in themitochondrial outer membrane
can lead to mitochondrial fragmentation and the formation of
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perinuclear clusters of morphologically altered mitochondria,
finally inducing the activation of autophagy (Oude Ophuis et al.,
2009).
DM-patients’ muscles show a reduced expression of DMPK,
mitochondrial accumulation in degenerated myofibrils and
disorganization of the sarcoplasmic reticulum (Ueda et al., 1999).
On the other hand, these muscles show reduced Coenzyme Q10
(CoQ10) levels, a component of the electron transport chain that
participates in aerobic cellular respiration, generating energy as
ATP (Siciliano et al., 2001). Blood samples have confirmed an
inverse correlation between CoQ10 levels and CTG expansion
length in DM patients (Tedeschi et al., 2000).
As for DM2, proteomic analyses of myotubes have detected
abnormalities in two proteins involved in mitochondrial
fatty acid degradation and another two proteins involved
in the import, chaperonin and quality control functions of
mitochondria (Rusconi et al., 2010). The elongation factors Tu
and Ts, two posttranslational proteins that participate in the
mitochondrial translational machinery, were also reduced in
DM2 cultures. Mutations and/or reductions in these proteins
are associated with muscle hypotonia and decline of motor
skills (Valente et al., 2007). Therefore, mitochondrial dysfunction
seems to be common to both muscular aging and DM.
Deficiencies in Nutrient Sensing
DM patients show several metabolic defects that are also
common in aged individuals, such as glucose resistance,
hyperinsulinemia and in some cases, the development of
diabetes mellitus. Studies performed with large DM1 samples
have revealed that there are metabolic dysfunctions associated
with this disease, such as primary hyperparathyroidism,
calcium metabolism, thyroid insufficiency, hypogonadism,
hyperprolactinemia or diabetes. Some of these dysfunctions seem
to correlate with the length of the repeat expansion (Ørngreen
et al., 2012).
Hyperphosphorylation of CUGBP, which is a feature of DM,
leads to abnormal splicing of the IR mRNA, lacking exon 11
(Osborne et al., 2009). The IR is mainly expressed in skeletal
muscle and its binding to the ligands insulin and IGF-I activates
metabolic pathways implicated in muscle hypertrophy, whereas
binding to IGF-II induces mitosis. This binding affinity is
isoform-dependent; the form that lacks exon 11 (immature
form), is mainly expressed in embryonic tissues and shows high
affinity towards IGF-II, compared to insulin and IGF-I. Due to
the abnormal splicing, DM skeletal muscles are characterized by
a predominant expression of the immature isoform, which leads
to insulin insensitivity (Savkur et al., 2001, 2004). This splicing
defect seems to be independent of muscle fiber type, as both
fiber types show a reduced expression of the adult IR isoform
(Santoro et al., 2013), despite DM muscle wasting being fiber-
type dependent (Vihola et al., 2003; Pisani et al., 2008).
These splicing abnormalities have been observed in muscle
tissue and myotube cultures of both DM1 and DM2 patients
prior to the development of muscle histopathology, which
indicates that DM1 and DM2 share common pathogenic
mechanisms and that these splicing abnormalities appear before
myofiber degeneration (Santoro et al., 2013).
Insulin secretion has also been found to be abnormal in
DM patients, probably due to loss of calcium homeostasis that
regulates insulin secretion by pancreatic beta-cells (Savkur et al.,
2001).
Thus, deficiencies in nutrient sensing are shared by both
physiological aging and DM patients, which leads to the use of
common therapeutic approaches to treat both conditions.
Concluding Remarks
Myotonic dystrophies represent a new paradigm of how a
genetically determined disease initiates a cascade of events
that lead to a wide variety of symptoms (myotonia, cataracts,
heart dysfunction, baldness, etc.) that resemble the multisystem
involvement induced by aging.
Different pathogenic mechanisms exist to explain how these
tandem expansions in the genome of affected patients lead to the
DM phenotype, although it has not yet been clearly defined to
what degree each mechanism contributes to the development of
the disease.
An important feature of myotonic dystrophies and aging
resides in their progressive nature. The described molecular
events, such as genomic instability, alteration of autophagy or
mitochondrial dysfunction, among others, induce cell damage
that continues to accumulate throughout life (Figure 4).
Satellite cells have been hypothesized to be the main
contributors to muscle regeneration. Numerous studies have
established that both cell-intrinsic and environmental factors
induce the age-related decline of their regenerative capacity in
muscle aging and sarcopenia. However, it is still unclear how
these cells behave in different muscle dystrophies and if their
FIGURE 4 | The figure represents six cellular events that happen in
both aging and myotonic dystrophy.
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loss of regenerative potential is crucial in muscle wasting seen in
affected patients.
The molecular pathologic mechanisms of DM, as well as
the aging-related events reviewed above, strongly suggest that
satellite cell dysfunction could be a major contributor to the
development of muscle wasting in these patients and thus, that
these cells could become potential targets for the treatment
of both age-related and DM-induced muscle dysfunction. It
is worth highlighting that skeletal muscle fibers also present
proteostatic and mitochondrial abnormalities that resemble
general aging processes. Thus, DM patients and animal models
can be considered bona fide models of aging, and this should be
kept in mind when designing treatments to treat both myotonic
dystrophy patients and aging-derived disorders.
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